Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Biomedical Materials Research|January 1, 1979
Monomer release from methacrylate bone cements during simulated in vivo polymerizationC M Schoenfeld, G J Conard, E P LautenschlagerArzneimittel-Forschung|January 1, 1982
Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patientsG J Conard, G E Cronheim, H W KlemptClinical Pharmacology and Therapeutics|November 1, 1988
Pharmacokinetics of flecainide in patients with cirrhosis of the liverR L McQuinn, P J Pentikäinen, S F Chang, et al.Arzneimittel-Forschung|January 1, 1983
Measurement of flecainide acetate in human plasma by an extraction spectrophotofluorometric methodS F Chang, A M Miller, M J Jernberg, et al.Clinical Therapeutics|January 1, 1984
Plasma concentrations of flecainide acetate, a new antiarrhythmic agent, in humansG J Conard, G L Carlson, J W Frost, et al.Circulation|May 1, 1982
Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agentM Hodges, J M Haugland, G Granrud, et al.Journal of Clinical Pharmacology|August 1, 1988
Flecainide pharmacokinetics after multiple dosing in patients with impaired renal functionS C Forland, R E Cutler, R L McQuinn, et al.Journal of Clinical Pharmacology|January 1, 1986
The effect of flecainide acetate, a new antiarrhythmic, on plasma digoxin levelsC E Weeks, G J Conard, D C Kvam, et al.Clinical Pharmacology and Therapeutics|May 1, 1988
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmiasT Wang, L A Siddoway, K A Thompson, et al.Pageof 2